current and future pharmacy practice

This event will focus on pharmacists’ roles in influenza prevention through vaccination and increasing influenza vaccination coverage rate.

Artificial intelligence is changing how pharmaceutical companies operate, how they develop and study new treatments, and even what form those treatments take. Pharma companies are now pairing medicines with software — so-called digiceuticals powered by virtual reality and AI. Most of the world’s largest drug companies now have a technology officer in their C-suites. And AI is now being used to help find new drug targets, model diseases, and make clinical trials more efficient.

Many Health Information Management departments are still prepping charts that come from all departments of a hospital system. This means that there is a potential time lag in making this critical information available to providers. The first place to start is selecting a document imaging solution for any paper being produced outside of your EMR system. But let's take this a step further. What if we move document imaging out of the HIM department and into each clinical area of a hospital?

Therapeutic approaches for Parkinson’s disease are either focused on disease modification (a-synuclein or MPTP models) or symptom management (haloperidol or 6-OHDA models). Therapeutic approaches for Parkinson’s disease are either focused on disease modification (a-synuclein or MPTP models) or symptom management (haloperidol or 6-OHDA models). Our scientists have validated available PD models for changes in fine motor skills, L-dopa-induced dyskinesias, drug-induced jaw movements, and non-motor endpoints such as cognition, constipation, and EDS. Additionally, we have also tested dopamine and other neurotransmitter levels in brain compartments of rodent and large animal models via microdialysis sampling.